HealthEquity (HQY) Stock Price, News & Analysis

Company Overview

HealthEquity, Inc. provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits. Its services also include COBRA administration, commuter benefits, lifestyle spending accounts, and related benefits administration capabilities.

HealthEquity primarily serves employers, health plans, benefits advisors, and their employees and members in the United States. The company was founded in 2002 and expanded its benefits administration platform through acquisitions, including its 2019 acquisition of WageWorks. HealthEquity is headquartered in Draper, Utah, and is led by Chief Executive Officer Jon Kessler.

Key Stats

• Today's Range: $100.55 to $103.35
• 50-Day Range: $87.25 to $105.41
• 52-Week Range: $72.76 to $107.62
• Volume: 630,892 shs
• Average Volume: 939,443 shs
• Market Capitalization: $8.38 billion
• P/E Ratio: 36.58
• Dividend Yield: N/A
• Price Target: $113.53
• Consensus Rating: Moderate Buy

HealthEquity Stock Analysis - MarketRank™

HealthEquity scored higher than 85% of companies evaluated by MarketBeat, and ranked 55th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

HealthEquity has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 1 strong buy rating, 11 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

HealthEquity has a consensus price target of $113.53, representing about 12.0% upside from its current price of $101.34.

Amount of Analyst Coverage

HealthEquity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 17.56%

Earnings Growth

Earnings for HealthEquity are expected to grow by 17.56% in the coming year, from $3.93 to $4.62 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of HealthEquity is 36.58, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of HealthEquity is 36.58, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.86.

Price to Earnings Growth Ratio

HealthEquity has a PEG Ratio of 1.64. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

HealthEquity has a P/B Ratio of 4.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.30% of the float of HealthEquity has been sold short.

Short Interest Ratio / Days to Cover

HealthEquity has a short interest ratio ("days to cover") of 7.79.

Change versus previous month

Short interest in HealthEquity has recently decreased by 0.80%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

HealthEquity does not currently pay a dividend.

Dividend Growth

HealthEquity does not have a long track record of dividend growth.

News and Social Media

• Score: 4.6 / 5
• News Sentiment: 1.29

News Sentiment

HealthEquity has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for HealthEquity this week, compared to 3 articles on an average week.

Search Interest

4 people have searched for HQY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

2 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 2.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, HealthEquity insiders have sold 8,200.41% more of their company's stock than they have bought. Specifically, they have bought $9,756.00 in company stock and sold $809,788.00 in company stock.

Percentage Held by Insiders

1.60% of the stock of HealthEquity is held by insiders.

Percentage Held by Institutions

99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/27/2026
• Today: 10/28/2026
• Next Earnings (Estimated): 12/02/2026
• Fiscal Year End: 1/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NASDAQ:HQY
• CIK: 1428336
• Web: www.healthequity.com
• Phone: (801) 727-1000
• Fax: 801-727-1005
• Employees: 2,814
• Year Founded: 2002

Price Target and Rating

• Average Price Target for HealthEquity: $113.53
• High Price Target: $142.00
• Low Price Target: $89.00
• Potential Upside/Downside: +12.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.92
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.77
• Trailing P/E Ratio: 36.58
• Forward P/E Ratio: 25.79
• P/E Growth: 1.64
• Net Income: $215.20 million
• Net Margins: 17.36%
• Pretax Margin: 22.66%
• Return on Equity: 15.33%
• Return on Assets: 9.51%

Debt

• Debt-to-Equity Ratio: 0.47
• Current Ratio: 2.99
• Quick Ratio: 2.99

Sales & Book Value

• Annual Sales: $1.31 billion
• Price / Sales: 6.38
• Cash Flow: $5.14 per share
• Price / Cash Flow: 19.71
• Book Value: $24.66 per share
• Price / Book: 4.11

Miscellaneous

• Outstanding Shares: 82,710,000
• Free Float: 81,392,000
• Market Cap: $8.38 billion
• Optionable: Optionable
• Beta: 0.24